Macrophage migration inhibitory factor Antagonist blocks the development of endometriosis in vivo

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Khoufache, Khaled ^a   Bazin, Sylvie ^b   Girard, Karine ^b   Guillemette, Julie ^b   Roy, Marie Christine ^b   Verreault, Jean Pierre ^b   Al Abed, Yousef ^c   Foster, Warren ^d   Akoum, Ali ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 HYDROXYPHENYL) 4,5 DIHYDRO 5 ISOXAZOLE ACETIC METHYL ESTER; ALPHA5 INTEGRIN; BETA3 INTEGRIN; CYCLOOXYGENASE 2; CYTOKINE RECEPTOR ANTAGONIST; GELATINASE A; GELATINASE B; INTERLEUKIN 8; ISO 1; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULOTROPIN; 3 (4 HYDROXYPHENYL) 4,5 DIHYDRO 5 ISOXAZOLEACETIC ACID METHYL ESTER; 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID METHYL ESTER; CD51 ANTIGEN; ISOMERASE; ISOXAZOLE DERIVATIVE; MIF PROTEIN, HUMAN; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; PRIMER DNA; PTGS2 PROTEIN, MOUSE; VASCULOTROPIN A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SURVIVAL RATE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION;

MUS; MUS MUSCULUS;

ANIMALS; CELL ADHESION; CYCLOOXYGENASE 2; DNA PRIMERS; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; HISTOLOGICAL TECHNIQUES; HUMANS; INTEGRIN ALPHAV; INTEGRIN BETA3; INTERLEUKIN-8; INTRAMOLECULAR OXIDOREDUCTASES; ISOXAZOLES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861384728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037264     Document Type: Article

References (74)

1. Giudice LC, (2010) Clinical practice. Endometriosis. N Engl J Med 362: 2389-2398.
2. Holoch KJ, Lessey BA, (2010) Endometriosis and infertility. Clin Obstet Gynecol 53: 429-438.
3. Painter JN, Anderson CA, Nyholt DR, Macgregor S, Lin J, et al. (2011) Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 43: 51-54.
4. Simpson JL, Elias S, Malinak LR, Buttram VC Jr, (1980) Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 137: 327-331.
5. Anger DL, Foster WG, (2008) The link between environmental toxicant exposure and endometriosis. Front Biosci 13: 1578-1593.
6. Colette S, Donnez J, (2011) Are aromatase inhibitors effective in endometriosis treatment? Expert opinion on investigational drugs.
7. Check JH, (2011) Chronic pelvic pain syndromes-traditional and novel therapies: part I surgical therapy. Clinical and experimental obstetrics & gynecology 38: 10-13.
8. Taylor RN, Mueller MD, (2004) Anti-angiogenic treatment of endometriosis: biochemical aspects. Gynecol Obstet Invest 57: 54-56.
9. Bondza PK, Maheux R, Akoum A, (2009) Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed) 1: 415-428.
10. Akoum A, Lemay A, McColl S, Turcot-Lemay L, Maheux R, (1996) Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 66: 17-23.
11. Kats R, Collette T, Metz CN, Akoum A, (2002) Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril 78: 69-76.
12. Akoum A, Kong J, Metz C, Beaumont MC, (2002) Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 77: 989-994.
13. Rana N, Braun DP, House R, Gebel H, Rotman C, et al. (1996) Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 65: 925-930.
14. McLaren J, Prentice A, Charnock-Jones DS, Sharkey AM, Smith SK, (1997) Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 12: 146-152.
15. Olive DL, Montoya I, Riehl RM, Schenken RS, (1991) Macrophage-conditioned media enhance endometrial stromal cell proliferation in vitro. Am J Obstet Gynecol 164: 953-958.
16. Chuang PC, Lin YJ, Wu MH, Wing LY, Shoji Y, et al. (2010) Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis. Am J Pathol 176: 850-860.
17. Akoum A, Metz CN, Al-Akoum M, Kats R, (2006) Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil Steril 85: 1379-1385.
18. Morin M, Bellehumeur C, Therriault MJ, Metz C, Maheux R, et al. (2005) Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil Steril 83: 865-872.
19. Kats R, Metz CN, Akoum A, (2002) Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab 87: 883-889.
20. Lin W, Chen S, Li M, Wang B, Qu X, et al. (2010) Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility. J Obstet Gynaecol Res 36: 344-351.
21. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, et al. (2008) Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 89: 1073-1081.
22. Mahutte NG, Matalliotakis IM, Goumenou AG, Koumantakis GE, Vassiliadis S, et al. (2004) Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis. Fertil Steril 82: 97-101.
23. Bloom BR, Bennett B, (1970) Relation of the migration inhibitory factor (MIF) to delayed-type hypersensitivity reactions. Annals of the New York Academy of Sciences 169: 258-265.
24. Calandra T, Bucala R, (1997) Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Critical reviews in immunology 17: 77-88.
25. Roger T, Froidevaux C, Martin C, Calandra T, (2003) Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4). Journal of endotoxin research 9: 119-123.
26. Taylor JA, 3rd, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, et al. (2007) Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC cancer 7: 135.
27. Bach JP, Deuster O, Balzer-Geldsetzer M, Meyer B, Dodel R, et al. (2009) The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 115: 2031-2040.
28. Carli C, Metz CN, Al-Abed Y, Naccache PH, Akoum A, (2009) Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology 150: 3128-3137.
29. Yang Y, Degranpre P, Kharfi A, Akoum A, (2000) Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 85: 4721-4727.
30. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, et al. (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5: 181-191.
31. Bondza PK, Metz CN, Akoum A, (2007) Postgestational effects of macrophage migration inhibitory factor on embryonic implantation in mice. Fertil Steril.
32. Chen PF, Luo YL, Wang W, Wang JX, Lai WY, et al. (2010) ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Molecular medicine 16: 400-408.
33. Hou XQ, Gao YW, Yang ST, Wang CY, Ma ZY, et al. (2009) Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta virologica 53: 225-231.
34. Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, et al. (2007) Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes and immunity 8: 646-652.
35. Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, et al. (2003) Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Annals of the New York Academy of Sciences 995: 171-182.
36. Stojanovic I, Mirkov I, Kataranovski M, Glamoclija J, Stosic-Grujicic S, (2011) A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus. Immunobiology.
37. Veillat V, Carli C, Metz CN, Al-Abed Y, Naccache PH, et al. (2010) Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab 95: E403-412.
38. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, et al. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. The Journal of biological chemistry 280: 36541-36544.
39. Noyes RW, Hertig AT, Rock J, (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122: 262-263.
40. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, et al. (2009) Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. Journal of immunology 182: 7795-7802.
41. Wenzl RJ, Heinzl H, (1998) Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 45: 253-257.
42. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, et al. (2002) Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 78: 787-795.
43. Bellehumeur C, Collette T, Maheux R, Mailloux J, Villeneuve M, et al. (2005) Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis. Hum Reprod 20: 1177-1184.
44. Banu SK, Lee J, Speights VO Jr, Starzinski-Powitz A, Arosh JA, (2008) Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 149: 1180-1189.
45. Barcz E, Rozewska ES, Kaminski P, Demkow U, Bobrowska K, et al. (2002) Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. Int J Gynaecol Obstet 79: 229-235.
46. Akoum A, Lawson C, McColl S, Villeneuve M, (2001) Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 7: 859-866.
47. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M, (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13: 1686-1690.
48. Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, et al. (2011) Lymphocytes in endometriosis. American journal of reproductive immunology 65: 1-10.
49. Dmowski WP, Gebel H, Braun DP, (1998) Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. Hum Reprod Update 4: 696-701.
50. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, et al. (1998) Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril 69: 1042-1047.
51. Bach JP, Rinn B, Meyer B, Dodel R, Bacher M, (2008) Role of MIF in inflammation and tumorigenesis. Oncology 75: 127-133.
52. Mahutte NG, Matalliotakis IM, Goumenou AG, Koumantakis GE, Vassiliadis S, et al. (2004) Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis. Fertility and sterility 82: 97-101.
53. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, et al. (2008) Panel of markers can accurately predict endometriosis in a subset of patients. Fertility and sterility 89: 1073-1081.
54. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, et al. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280: 36541-36544.
55. Harada T, Taniguchi F, Izawa M, Ohama Y, Takenaka Y, et al. (2007) Apoptosis and endometriosis. Front Biosci 12: 3140-3151.
56. Hii LL, Rogers PA, (1998) Endometrial vascular and glandular expression of integrin alpha(v)beta3 in women with and without endometriosis. Hum Reprod 13: 1030-1035.
57. Brooks PC, Clark RA, Cheresh DA, (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571.
58. Osteen KG, Igarashi TM, Yeaman GR, Bruner-Tran KL, (2004) Steroid and cytokine regulation of matrix metalloproteinases and the pathophysiology of endometriosis. Gynecol Obstet Invest 57: 53-54.
59. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, et al. (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98: 482-489.
60. Meyer-Siegler KL, Leifheit EC, Vera PL, (2004) Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4: 34.
61. Morand EF, Leech M, (2005) Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 10: 12-22.
62. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, et al. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A 100: 9354-9359.
63. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, et al. (2003) Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 48: 1881-1889.
64. Petrenko O, Fingerle-Rowson G, Peng T, Mitchell RA, Metz CN, (2003) Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation. J Biol Chem 278: 11078-11085.
65. Meyer-Siegler K, (2000) Macrophage migration inhibitory factor increases MMP-2 activity in DU-145 prostate cells. Cytokine 12: 914-921.
66. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, et al. (2002) Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and-13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 277: 7865-7874.
67. Bondza PK, Metz CN, Akoum A, (2008) Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa. J Reprod Immunol 77: 142-151.
68. Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, et al. (2003) Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci 995: 171-182.
69. Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, et al. (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93: 321-329.
70. Ren Y, Chan HM, Li Z, Lin C, Nicholls J, et al. (2004) Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23: 4146-4154.
71. Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, et al. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. The Journal of biological chemistry 277: 24976-24982.
72. Shi X, Leng L, Wang T, Wang W, Du X, et al. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606.
73. Budzynski W, Radzikowski C, (1994) Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol 16: 319-346.
74. Murk W, Atabekoglu CS, Cakmak H, Heper A, Ensari A, et al. (2008) Extracellularly signal-regulated kinase activity in the human endometrium: possible roles in the pathogenesis of endometriosis. J Clin Endocrinol Metab 93: 3532-3540.